IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 256 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $2,743,678 | +150.8% | 239,832 | +111.1% | 0.01% | +120.0% |
Q3 2023 | $1,093,939 | -88.7% | 113,597 | -87.5% | 0.01% | -89.1% |
Q2 2023 | $9,649,682 | +162.2% | 906,925 | +159.2% | 0.05% | +155.6% |
Q1 2023 | $3,680,285 | +132.9% | 349,837 | +174.3% | 0.02% | +100.0% |
Q4 2022 | $1,580,295 | -43.0% | 127,546 | -47.0% | 0.01% | -35.7% |
Q2 2022 | $2,772,000 | +794.2% | 240,431 | +876.0% | 0.01% | +600.0% |
Q1 2022 | $310,000 | -78.2% | 24,634 | -80.7% | 0.00% | -80.0% |
Q1 2021 | $1,425,000 | +285.1% | 127,473 | +292.0% | 0.01% | +233.3% |
Q4 2020 | $370,000 | +191.3% | 32,516 | +159.2% | 0.00% | -25.0% |
Q1 2020 | $127,000 | -74.3% | 12,546 | -66.3% | 0.00% | -60.0% |
Q4 2019 | $495,000 | – | 37,225 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
13D Management LLC | 658,017 | $7,357,000 | 2.72% |
Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |